top of page
Image by Mitchell Griest



We are dedicated to finding better treatments for rare cancers like Zain's. Through our partnerships with leading cancer experts, we are working to advance treatments and to provide hope that we can make a difference in the fight against rare cancers. Below you will find more information and articles.

Dr. Lisa Giulino-Roth   

Dr. Lisa Roth Headshot.png

Dr. Roth is the Director of Pediatric Oncology and an Associate Professor in the Departments of Pediatrics, Medicine and Pathology and Laboratory Medicine at Weill Cornell Medicine, where she served as the Charles, Lillian and Betty Neuwirth Clinical Scholar in Pediatric Oncology from 2013-2019.  She is also an Associate Attending Pediatrician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.  

Dr. Roth specializes in treating children, adolescents and young adults with lymphoma and leukemia. She is a member of the Children’s Oncology Group and an active participant in Hodgkin lymphoma and non-Hodgkin lymphoma clinical trials. She is also a member of the Weill Cornell Center for Lymphoma, a group which is internationally recognized for its leadership in the treatment of patients with lymphoma.     

Dr. Roth’s research focuses on identifying new treatments for children with lymphoma.  She is particularly interested identifying novel targeted therapies. Targeted therapies may be less toxic than conventional chemotherapy and may be able to rescue those patients with chemotherapy-resistant disease. Dr. Roth has been recognized for her work with awards from the National Institutes of Health (NIH), the Lymphoma Research Foundation, Hyundai Hope on Wheels Foundation, and the St. Baldrick's Foundation.


American Society of Hematology 

How I treat primary mediastinal B-cell lymphoma 

Outcomes of Adults and Children.png

British Journal of Haematology

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R

bottom of page